Hemmie Chang is a Partner at Foley Hoag LLP, where she chairs the Licensing & Strategic Alliances Practice Group and focuses on complex collaboration and licensing transactions. She is a member of the firm’s Life Sciences, Venture Capital & Emerging Companies, and Energy Technology & Renewables practices. Hemmie has over two decades of experience advising both pharmaceutical and emerging biotech companies on IP transactions, including the acquisition and disposition of assets.
Practice Areas and Industry Focus
- Venture Capital & Emerging Companies
- Life Sciences
- Business
- Intellectual Property
- Licensing & Strategic Alliances
Representative Experience
- Mergers and acquisitions and licensing transactions for major pharmaceutical and emerging high-growth companies
- Representation of lead investor in an over $1 billion investment in the largest contract research organization worldwide
- Representation of a bidder for a Fortune 100 company’s sale of its imaging business
- Investments, mergers and acquisitions and financings in energy and renewables (solar, wind) and other projects
- Represented numerous entities in collaboration and licensing agreements and financing transactions with venture capital firms
Speaking Engagements
- "State of Licensing 2011 Update," Biotechnology Industry Organization's 2011 Webinar (May 2011)
- “Starting a Business in China: Legal Considerations,” MIT Sloan 2010 Asia Business Conference (November 2010)
- “Current Trends of Global M&A,” Global Bio & Medical Forum 2010 (June 2010)
- “How to Acquire New Products and Technologies: What’s New/What’s Not,” Biotechnology Industry Organization’s 2010 Annual Meeting (May 2010)